This study presents SynaptoGen, a differentiable extension of connectome models that links gene expression, protein-protein interaction probabilities, synaptic multiplicity, and synaptic weights, and ...

A pioneering study has found that an individualized approach to breast cancer screening that assesses patients' risk, rather ...

Ahmedabad-based Zydus Lifesciences Ltd has inked a pact with precision diagnostics company Myriad Genetics from the USA to ...

Zydus partners with Myriad Genetics to introduce advanced cancer-risk assessment tests, enhancing precision diagnostics in India.

A research group at the Italian Institute of Technology (IIT-Istituto Italiano di Tecnologia) has identified a candidate ...

New research indicates that personalized breast cancer screening based on individual risk could improve detection while reducing unnecessary testing. A new study suggests that tailoring breast cancer ...